Aug 9 |
Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress
|
Jun 21 |
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
|
Jun 20 |
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
|
Jun 19 |
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
|
Jun 19 |
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
|
Jun 18 |
US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth
|
Jun 18 |
Top Midday Decliners
|
Jun 18 |
Zentalis falls after FDA partial clinical hold on lead asset
|
Jun 18 |
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
|
Jun 4 |
We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
|